Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

COGENT BIOSCIENCES INC (COGT)

264 + Investors. Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +76
Streak
2Q ▲
Buyers last Q
68%

Smart Money Signals — COGT

Based on 267 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
267 hedge funds hold COGT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +54% more funds vs a year ago

fund count last 6Q
+94 new funds entered over the past year (+54% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 68% buying

189 buying88 selling
Last quarter: 189 funds were net buyers (96 opened a brand new position + 93 added to an existing one). Only 88 were sellers (68 trimmed + 20 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+56 vs last Q)

new funds entering per quarter
Funds opening a new COGT position: 34 → 30 → 40 → 96. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 23% medium ■ 34% new
114 out of 267 hedge funds have held COGT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +165% but shares only +9% — price-driven

Value
+165%
Shares
+8%
Last quarter: the total dollar value of institutional holdings rose +165%, but actual share count only changed +9%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

36 → 34 → 30 → 40 → 96 new funds/Q
New funds entering each quarter: 34 → 30 → 40 → 96. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 55% of holders stayed 2+ years

■ 55% veterans ■ 10% 1-2yr ■ 36% new
Of 273 current holders: 149 (55%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 39% AUM from major funds

39% from top-100 AUM funds
48 of 267 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — COGT

In 2025 Q4, 189 hedge funds were net buyers of COGT (96 opened a new position, 93 added to an existing one), while 88 reduced or exited (68 trimmed, 20 sold completely) — a 68% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 39% of total institutional value in COGT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +76 funds (more new holders than closures). Total institutional holders: 267.

Hedge Fund Ownership: COGT

How many hedge funds hold COGT — quarterly history vs. share price
Quarterly hedge fund ownership of COGT vs. share price

Market Analysis: COGT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: COGT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy COGENT BIOSCIENCES INC (COGT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much COGT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 49d ago
COGT
-15.3%
XLV
-11.8%

COGT outperformed XLV by -3.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 4d ago
COGT
-4.0%
XLV
-5.2%

Since the filing became public, COGT outperformed XLV by +1.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

41 top-rated funds 12 high-conviction
Consensus
7.0
/ 10
breadth
×
Elite
4.6
/ 10
conviction
Hedge Fund Positioning: COGT
2026 Q1 Stats Unlock in 1 days 264 + Investors

Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 264 194 36.08%
13F Shares 175M 161M 8.88%
Total Value $6.11B $2.30B 165.45%
New Positions 92 40 +52
Increased Positions 107 93 +14
Closed Positions 19 29 -10
Reduced Positions 69 69 -
Total Calls 5 6 -16.67%
Total Puts 3 3 -
PUT/CALL Ratio 0.6 0.5 Bullish

Statistics: COGT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

264 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COGT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of COGT — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Fairmount Funds Management LLC 15.30% 5,503,418 $211.8M
2 Elmind Capital, LP 12.79% 1,170,740 $45.1M
3 Squadron Capital Management LLC 11.11% 787,492 $30.3M
4 Octagon Capital Advisors LP 10.01% 2,350,000 $90.5M
5 Kynam Capital Management, LP 9.59% 4,037,331 $155.4M
6 Commodore Capital LP 6.43% 2,888,007 $111.2M
7 SUPERSTRING CAPITAL MANAGEMENT LP 6.19% 225,158 $8.7M
8 Exome Asset Management LLC 5.54% 278,533 $10.7M
9 TCG Crossover Management, LLC 5.45% 4,946,894 $190.4M
10 SILVERARC CAPITAL MANAGEMENT, LLC 5.16% 1,314,189 $50.6M
11 Saturn V Capital Management LP 4.37% 626,635 $24.1M
12 DEERFIELD MANAGEMENT COMPANY, L.P. 4.11% 9,043,903 $348.1M
13 First Turn Management, LLC 4.07% 947,339 $36.5M
14 Patient Square Capital LP 4.07% 596,000 $22.9M
15 Sofinnova Investments, Inc. 3.09% 2,113,551 $81.4M
16 Venrock Adviser, LLC 2.87% 2,000,000 $77.0M
17 SPHERA FUNDS MANAGEMENT LTD. 2.54% 416,340 $16.0M
18 Knott David M Jr 2.38% 104,000 $4.0M
19 NEXTBio Capital Management LP 2.34% 131,188 $5.0M
20 DIADEMA PARTNERS LP 2.11% 322,764 $12.4M
21 HighVista Strategies LLC 2.09% 197,051 $7.6M
22 RTW INVESTMENTS, LP 2.09% 5,458,675 $210.1M
23 EMERALD ADVISERS, LLC 1.93% 1,588,132 $61.1M
24 EMERALD MUTUAL FUND ADVISERS TRUST 1.92% 1,028,832 $39.6M
25 Defilade Capital Management, L.P. 1.91% 352,590 $13.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — COGENT BIOSCIENCES INC (COGT)

What does the Smart Money Trend signal show for COGT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for COGT?

More buyers than sellers — 68% buying: Last quarter: 189 funds were net buyers (96 opened a brand new position + 93 added to an existing one). Only 88 were sellers (68 trimmed + 20 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for COGT holders?

Strong quality — 39% AUM from major funds: 48 of 267 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held COGT?

43% of holders stayed for 2+ years: 114 out of 267 hedge funds have held COGT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy COGENT BIOSCIENCES INC (COGT) following the 2026 Q1 hedge fund 13F filings?

As of today, COGT has moved -4.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to -5.2% for the XLV sector ETF — an outperformance of +1.2%. Since the quarter end (March 31, 2026), COGT has gained -15.3% vs -11.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.